ProfileGDS4718 / 202168_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 89% 87% 84% 88% 89% 92% 93% 90% 85% 91% 90% 84% 94% 90% 88% 90% 91% 88% 89% 80% 90% 90% 87% 89% 88% 90% 87% 89% 83% 89% 90% 91% 84% 88% 89% 94% 86% 88% 90% 86% 90% 93% 87% 86% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]9.1467789
GSM549102patient 115, normal, homogenized [OPG study]8.6933387
GSM549104patient 119, normal, homogenized [OPG study]8.4084584
GSM549108patient 138, normal, homogenized [OPG study]8.7807388
GSM549119patient 077, normal, homogenized [OPG study]9.009689
GSM549133patient 032, cancer, homogenized [OPG study]9.6465892
GSM549139patient 042, cancer, homogenized [OPG study]9.7204793
GSM549099patient 107, normal, homogenized [OPG study]9.1742190
GSM549109patient 139, normal, homogenized [OPG study]8.4044785
GSM549110patient 046, normal, homogenized [OPG study]9.4392391
GSM549114patient 063, normal, homogenized [OPG study]9.3560290
GSM549122patient 082, normal, homogenized [OPG study]8.3972484
GSM549134patient 033, cancer, homogenized [OPG study]10.07994
GSM549136patient 036, cancer, homogenized [OPG study]9.2244290
GSM549140patient 044, cancer, homogenized [OPG study]8.9813788
GSM549111patient 047, normal, homogenized [OPG study]9.3469790
GSM549113patient 057, normal, homogenized [OPG study]9.4703191
GSM549132patient 031, cancer, homogenized [OPG study]8.8453788
GSM549137patient 038, cancer, homogenized [OPG study]8.9709389
GSM549142patient 047, cancer, homogenized [OPG study]7.631980
GSM549100patient 110, normal, homogenized [OPG study]9.1157290
GSM549107patient 135, normal, homogenized [OPG study]9.3271190
GSM549115patient 068, normal, homogenized [OPG study]8.8536387
GSM549116patient 072, normal, homogenized [OPG study]9.1972389
GSM549120patient 078, normal, homogenized [OPG study]8.9436388
GSM549131patient 030, cancer, homogenized [OPG study]9.194990
GSM549118patient 074, normal, homogenized [OPG study]8.7494487
GSM549129patient 027, cancer, homogenized [OPG study]8.8915689
GSM549123patient 088, normal, homogenized [OPG study]8.1887183
GSM549124patient 006, cancer, homogenized [OPG study]8.9347289
GSM549126patient 015, cancer, homogenized [OPG study]9.0565790
GSM549128patient 025, cancer, homogenized [OPG study]9.303991
GSM549103patient 117, normal, homogenized [OPG study]8.1531584
GSM549117patient 073, normal, homogenized [OPG study]8.9945688
GSM549138patient 041, cancer, homogenized [OPG study]9.087189
GSM549141patient 045, cancer, homogenized [OPG study]10.12394
GSM549130patient 028, cancer, homogenized [OPG study]8.5399186
GSM549101patient 111, normal, homogenized [OPG study]8.7527988
GSM549105patient 128, normal, homogenized [OPG study]9.2337790
GSM549106patient 134, normal, homogenized [OPG study]8.7792286
GSM549112patient 048, normal, homogenized [OPG study]9.2978790
GSM549125patient 011, cancer, homogenized [OPG study]9.6196693
GSM549127patient 024, cancer, homogenized [OPG study]8.7315387
GSM549135patient 035, cancer, homogenized [OPG study]8.6950486